Suppr超能文献

肾功能降低与红细胞叶酸浓度增加以及叶酸形式分布变化相关(NHANES 2011-2018)。

Reduced Kidney Function Is Associated with Increasing Red Blood Cell Folate Concentration and Changes in Folate Form Distributions (NHANES 2011-2018).

机构信息

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.

Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.

出版信息

Nutrients. 2022 Mar 2;14(5):1054. doi: 10.3390/nu14051054.

Abstract

Background: Current studies examining the effects of high concentrations of red blood cell (RBC) or serum folates assume that high folate concentrations are an indicator of high folic acid intakes, often ignoring the contributions of other homeostatic and biological processes, such as kidney function. Objective: The current study examined the relative contributions of declining kidney function, as measured by the risk of chronic kidney disease (CKD), and usual total folic acid intake on the concentrations of RBC folate and serum folate (total as well as individual folate forms). Design: Cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) collected in 2-year cycles were combined from 2011 to 2018. A total of 18,127 participants aged ≥16 years with available folate measures, kidney biomarker data (operationalized as a categorical CKD risk variable describing the risk of progression), and reliable dietary recall data were analyzed. Results: RBC folate concentrations increased as CKD risk increased: low risk, 1089 (95% CI: 1069, 1110) nmol/L; moderate risk, 1189 (95% CI: 1158, 1220) nmol/L; high risk, 1488 (95% CI: 1419, 1561) nmol/L; and highest risk, 1443 (95% CI: 1302, 1598) nmol/L (p < 0.0001). Similarly, serum total folate concentrations increased as CKD risk increased: low risk: 37.1 (95% CI: 26.3, 38.0) nmol/L; moderate risk: 40.2 (95% CI: 38.8, 41.7) nmol/L; high risk: 48.0 (95% CI: 44.3, 52.1) nmol/L; the highest Risk: 42.8 (95% CI: 37.8, 48.4) nmol/L (p < 0.0001). The modeled usual intake of folic acid showed no difference among CKD risk groups, with a population median of 225 (interquartile range: 108−390) µg/day. Conclusion: Both RBC and serum folate concentrations increased with declining kidney function without increased folic acid intake. When analyzing associations between folate concentrations and disease outcomes, researchers may want to consider the confounding role of kidney function.

摘要

背景

目前研究红细胞(RBC)或血清叶酸浓度的影响时,假设高叶酸浓度是叶酸摄入量高的指标,而经常忽略了其他稳态和生物学过程的影响,如肾功能。目的:本研究旨在探讨肾功能下降(通过慢性肾脏病(CKD)风险来衡量)和通常的总叶酸摄入量对红细胞叶酸和血清叶酸(总叶酸和单个叶酸形式)浓度的相对贡献。设计:对 2011 年至 2018 年期间以 2 年为周期收集的国家健康和营养检查调查(NHANES)的横断面数据进行了合并。共纳入了 18127 名年龄≥16 岁、有叶酸检测、肾功能生物标志物数据(定义为描述进展风险的 CKD 风险变量的分类变量)和可靠饮食回忆数据的参与者。结果:随着 CKD 风险的增加,RBC 叶酸浓度升高:低风险组为 1089(95%CI:1069,1110)nmol/L;中风险组为 1189(95%CI:1158,1220)nmol/L;高风险组为 1488(95%CI:1419,1561)nmol/L;最高风险组为 1443(95%CI:1302,1598)nmol/L(p<0.0001)。同样,随着 CKD 风险的增加,血清总叶酸浓度也升高:低风险组为 37.1(95%CI:26.3,38.0)nmol/L;中风险组为 40.2(95%CI:38.8,41.7)nmol/L;高风险组为 48.0(95%CI:44.3,52.1)nmol/L;最高风险组为 42.8(95%CI:37.8,48.4)nmol/L(p<0.0001)。模型化的通常叶酸摄入量在 CKD 风险组之间没有差异,人群中位数为 225(四分位距:108-390)µg/天。结论:红细胞和血清叶酸浓度随着肾功能下降而升高,而叶酸摄入量没有增加。在分析叶酸浓度与疾病结局之间的关系时,研究人员可能需要考虑肾功能的混杂作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验